MicroTech Medical (Hangzhou), a healthcare company focused on diabetes management, has priced a HK$1.94bn (US$249m) Hong Kong IPO at HK$30.50 per share, just short of the maximum marketed price of …
( read original story …)
The HongKong News
MicroTech Medical (Hangzhou), a healthcare company focused on diabetes management, has priced a HK$1.94bn (US$249m) Hong Kong IPO at HK$30.50 per share, just short of the maximum marketed price of …
( read original story …)